ICOS Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (854)	10/25/2001 12:54:36 PM
From: Icebrg	Read Replies (1) of 1139

ICOS Corporation [ICOS $55.00] 12-Month Price Target: $68.00 2001E EPS: ($1.50), up from ($1.75) 2002E EPS: ($1.00), down from ($0.09) Buy Robert Hazlett, Large Capitalization/Specialty Pharmaceuticals (Robbie Stephens) We reiterate our Buy rating on ICOS shares due to the significant potential of Cialis, its PDE-5 inhibitor for erectile dysfunction. Long-term growth for ICOS will likely come from its promising emerging pipeline. In our opinion, ICOS shares recent pullback gives investors an excellent opportunity to participate in one of the highest quality names in biotechnology/emerging pharmaceuticals.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next